Suchergebnisse - "Moradi, Najmeh"

PubPharm (71)

1

A cost-benefit analysis of genetic screening test for breast cancer in Iran

enthalten in: BMC cancer | 2024

von Meshkani, Z. | Moradi, N. | Aboutorabi, A. | +2

2

Factor associated with willingness to pay for prevention of cancer : a study of prostate cancer screening

enthalten in: Cost effectiveness and resource allocation : C/E | 2023

von Farabi, H. | Moradi, N. | Ahmadzadeh, A. | +3

3

Evaluating the affordability of asthma, chronic obstructive pulmonary disease, and cystic fibrosis medicines in a middle-income country

enthalten in: BMC pulmonary medicine | 2023

von Fathi, M. | Moradi, N. | Yousefi, N. | +2

4

Evaluating the affordability of asthma, chronic obstructive pulmonary disease, and cystic fibrosis medicines in a middle-income country

enthalten in: BMC pulmonary medicine | 2023

von Fathi, M. | Moradi, N. | Yousefi, N. | +2

5

Economic evaluations of interventions to prevent and control health-care-associated infections : a systematic review

enthalten in: The Lancet. Infectious diseases | 2023

von Rice, S. | Carr, K. | Sobiesuo, P. | +12

ErratumIn: Lancet Infect Dis. 2023 May 15;:. - PMID 37201548

6

Subjective valuation of Iranian women for screening for gene-related diseases : a case of breast cancer

enthalten in: BMC public health | 2023

von Meshkani, Z. | Moradi, N. | Aboutorabi, A. | +2

7

Subjective valuation of Iranian women for screening for gene-related diseases: a case of breast cancer

enthalten in: BMC public health | 2023

von Meshkani, Z. | Moradi, N. | Aboutorabi, A. | +2

8

Subjective valuation of Iranian women for screening for gene-related diseases: a case of breast cancer

enthalten in: BMC public health | 2023

von Meshkani, Z. | Moradi, N. | Aboutorabi, A. | +2

9

Cost-utility analysis and net monetary benefit of Platelet Rich Plasma (PRP), intra-articular injections in compared to Plasma Rich in Growth Factors (PRGF), Hyaluronic Acid (HA) and ozone in knee osteoarthritis in Iran

enthalten in: BMC musculoskeletal disorders | 2023

von Raeissadat, S. | Rahimi, M. | Rayegani, S. | +1

10

Cost-utility analysis and net monetary benefit of Platelet Rich Plasma (PRP), intra-articular injections in compared to Plasma Rich in Growth Factors (PRGF), Hyaluronic Acid (HA) and ozone in knee osteoarthritis in Iran

enthalten in: BMC musculoskeletal disorders | 2023

von Raeissadat, S. | Rahimi, M. | Rayegani, S. | +1

1
2
3
4
5
6
7
8
Nächster »
[8]